aegislabs.com · 448
Aegis Labs has been a trusted partner for clinicians since 1990, providing a wide range of services to support confident care decisions. With offerings like PainComp®, InterACT Rx™, and AcuRise ID™, Aegis is dedicated to helping healthcare professionals navigate the complex landscape of infectious diseases and dangerous synthetic drugs. In addition, Aegis Sports Testing offers cutting-edge solutions for sports performance and safety. Explore our comprehensive services, including novel psychoactive substance testing, COVID-19 diagnostic testing, and patient portal access for streamlined care. Stay informed with our resources, webinars, clinical updates, and publications. Join our team and experience the expertise of Aegis Labs.
aegislabs.com · years statistic
1999
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 2 |
| 11 | 1 |
| 12 | 0 |
2000
| 1 | 0 |
| 2 | 0 |
| 3 | 1 |
| 4 | 0 |
| 5 | 1 |
| 6 | 1 |
| 7 | 1 |
| 8 | 1 |
| 9 | 0 |
| 10 | 3 |
| 11 | 0 |
| 12 | 1 |
2001
| 1 | 0 |
| 2 | 2 |
| 3 | 0 |
| 4 | 2 |
| 5 | 1 |
| 6 | 0 |
| 7 | 1 |
| 8 | 0 |
| 9 | 1 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2002
| 1 | 0 |
| 2 | 0 |
| 3 | 4 |
| 4 | 0 |
| 5 | 2 |
| 6 | 1 |
| 7 | 2 |
| 8 | 2 |
| 9 | 3 |
| 10 | 0 |
| 11 | 1 |
| 12 | 1 |
2003
| 1 | 1 |
| 2 | 1 |
| 3 | 3 |
| 4 | 1 |
| 5 | 2 |
| 6 | 3 |
| 7 | 2 |
| 8 | 1 |
| 9 | 2 |
| 10 | 3 |
| 11 | 2 |
| 12 | 4 |
2004
| 1 | 0 |
| 2 | 1 |
| 3 | 1 |
| 4 | 1 |
| 5 | 3 |
| 6 | 1 |
| 7 | 3 |
| 8 | 2 |
| 9 | 2 |
| 10 | 0 |
| 11 | 1 |
| 12 | 1 |
2005
| 1 | 1 |
| 2 | 5 |
| 3 | 2 |
| 4 | 0 |
| 5 | 5 |
| 6 | 1 |
| 7 | 2 |
| 8 | 1 |
| 9 | 2 |
| 10 | 1 |
| 11 | 2 |
| 12 | 3 |
2006
| 1 | 2 |
| 2 | 4 |
| 3 | 2 |
| 4 | 5 |
| 5 | 1 |
| 6 | 3 |
| 7 | 1 |
| 8 | 6 |
| 9 | 0 |
| 10 | 2 |
| 11 | 0 |
| 12 | 1 |
2007
| 1 | 0 |
| 2 | 0 |
| 3 | 3 |
| 4 | 0 |
| 5 | 1 |
| 6 | 1 |
| 7 | 1 |
| 8 | 0 |
| 9 | 2 |
| 10 | 7 |
| 11 | 1 |
| 12 | 1 |
2008
| 1 | 0 |
| 2 | 1 |
| 3 | 1 |
| 4 | 0 |
| 5 | 2 |
| 6 | 1 |
| 7 | 0 |
| 8 | 1 |
| 9 | 0 |
| 10 | 1 |
| 11 | 0 |
| 12 | 0 |
2009
| 1 | 1 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 1 |
| 6 | 0 |
| 7 | 1 |
| 8 | 1 |
| 9 | 0 |
| 10 | 1 |
| 11 | 0 |
| 12 | 1 |
2010
| 1 | 1 |
| 2 | 1 |
| 3 | 0 |
| 4 | 1 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2011
| 1 | 0 |
| 2 | 1 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 1 |
| 8 | 0 |
| 9 | 3 |
| 10 | 2 |
| 11 | 1 |
| 12 | 1 |
2012
| 1 | 1 |
| 2 | 1 |
| 3 | 2 |
| 4 | 1 |
| 5 | 1 |
| 6 | 2 |
| 7 | 0 |
| 8 | 1 |
| 9 | 0 |
| 10 | 1 |
| 11 | 0 |
| 12 | 0 |
2013
| 1 | 0 |
| 2 | 1 |
| 3 | 0 |
| 4 | 2 |
| 5 | 2 |
| 6 | 1 |
| 7 | 1 |
| 8 | 0 |
| 9 | 3 |
| 10 | 1 |
| 11 | 0 |
| 12 | 0 |
2014
| 1 | 0 |
| 2 | 2 |
| 3 | 2 |
| 4 | 0 |
| 5 | 1 |
| 6 | 1 |
| 7 | 1 |
| 8 | 1 |
| 9 | 1 |
| 10 | 1 |
| 11 | 0 |
| 12 | 3 |
2015
| 1 | 0 |
| 2 | 2 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 1 |
| 9 | 1 |
| 10 | 1 |
| 11 | 0 |
| 12 | 0 |
2016
| 1 | 7 |
| 2 | 1 |
| 3 | 5 |
| 4 | 1 |
| 5 | 2 |
| 6 | 0 |
| 7 | 0 |
| 8 | 1 |
| 9 | 0 |
| 10 | 4 |
| 11 | 1 |
| 12 | 0 |
2017
| 1 | 2 |
| 2 | 2 |
| 3 | 0 |
| 4 | 2 |
| 5 | 3 |
| 6 | 5 |
| 7 | 5 |
| 8 | 2 |
| 9 | 3 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2018
| 1 | 0 |
| 2 | 0 |
| 3 | 2 |
| 4 | 3 |
| 5 | 3 |
| 6 | 3 |
| 7 | 5 |
| 8 | 14 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2019
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 1 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2020
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 9 |
| 5 | 1 |
| 6 | 6 |
| 7 | 2 |
| 8 | 2 |
| 9 | 9 |
| 10 | 6 |
| 11 | 5 |
| 12 | 1 |
2021
| 1 | 1 |
| 2 | 6 |
| 3 | 2 |
| 4 | 3 |
| 5 | 2 |
| 6 | 3 |
| 7 | 0 |
| 8 | 2 |
| 9 | 2 |
| 10 | 3 |
| 11 | 2 |
| 12 | 3 |
2022
| 1 | 16 |
| 2 | 2 |
| 3 | 7 |
| 4 | 2 |
| 5 | 3 |
| 6 | 5 |
| 7 | 2 |
| 8 | 6 |
| 9 | 2 |
| 10 | 2 |
| 11 | 2 |
| 12 | 2 |
2023
| 1 | 2 |
| 2 | 7 |
| 3 | 7 |
| 4 | 5 |
| 5 | 2 |
| 6 | 4 |
| 7 | 1 |
| 8 | 5 |
| 9 | 1 |
| 10 | 0 |
| 11 | 0 |
| 12 | 2 |
2024
| 1 | 0 |
| 2 | 0 |
| 3 | 2 |
| 4 | 3 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
